214 related articles for article (PubMed ID: 16706826)
1. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C.
Takeo M; Kobayashi Y; Fujita N; Urawa N; Iwasa M; Horiike S; Tanaka H; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2005 Apr; 20(4):562-9. PubMed ID: 15836704
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
4. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
[TBL] [Abstract][Full Text] [Related]
6. Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences.
Tan MG; Kumarasinghe MP; Wang SM; Ooi LL; Aw SE; Hui KM
Exp Biol Med (Maywood); 2009 Jun; 234(6):693-702. PubMed ID: 19307463
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
Wallace DF; Summerville L; Subramaniam VN
Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
[TBL] [Abstract][Full Text] [Related]
8. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy.
Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM
Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968
[TBL] [Abstract][Full Text] [Related]
9. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C.
Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Kaneko S
Hepatology; 2006 Nov; 44(5):1122-38. PubMed ID: 17058214
[TBL] [Abstract][Full Text] [Related]
10. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
11. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease.
Suzuki Y; Saito H; Suzuki M; Hosoki Y; Sakurai S; Fujimoto Y; Kohgo Y
Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):26S-31S. PubMed ID: 12198371
[TBL] [Abstract][Full Text] [Related]
13. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
14. Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C.
Kageyama F; Kobayashi Y; Kawasaki T; Toyokuni S; Uchida K; Nakamura H
Am J Gastroenterol; 2000 Apr; 95(4):1041-50. PubMed ID: 10763957
[TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells in hepatitis C patients: relationship with the development of interstitial fibrosis in renal allografts.
Ozdemir BH; Bilezikçi B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2838-40. PubMed ID: 19765451
[TBL] [Abstract][Full Text] [Related]
16. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.
Bièche I; Asselah T; Laurendeau I; Vidaud D; Degot C; Paradis V; Bedossa P; Valla DC; Marcellin P; Vidaud M
Virology; 2005 Feb; 332(1):130-44. PubMed ID: 15661146
[TBL] [Abstract][Full Text] [Related]
18. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854
[TBL] [Abstract][Full Text] [Related]
19. Influence of Helicobacter pylori infection on iron accumulation in hepatitis C.
Sumida Y; Kanemasa K; Yamaoka Y; Imamura S; Katoh N; Nakashima T; Tachibana S; Mitsuyoshi H; Itoh Y; Okanoue T
Liver Int; 2006 Sep; 26(7):827-33. PubMed ID: 16911465
[TBL] [Abstract][Full Text] [Related]
20. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.
Ikura Y; Morimoto H; Johmura H; Fukui M; Sakurai M
Am J Gastroenterol; 1996 Jul; 91(7):1367-73. PubMed ID: 8677997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]